One in four children with COVID-19 symptoms develop “long COVID,” according to data pooled from 21 earlier studies conducted in Europe, Asia, Australia and South America. Also, according to a study reported on March 14 in JAMA Pediatrics, women who wish to pass protective antibodies induced by COVID-19 vaccines to their babies via breast milk should opt for the mRNA shots from Moderna or Pfizer/BioNTech.
The spread of COVID-19 in the Americas driven by the Omicron variant of the virus reached levels of transmission never before seen during the pandemic, with cases doubling to 6.1 million over the past week, the Pan American Health Organization (PAHO) said on January 12.
Covid-19 deaths decreased 17 percent in the Americas over the past week, but the most populous countries like the United States, Brazil and Colombia are seeing a leveling of new infections after weeks of declining trends, the Pan American Health Organization (PAHO) said on November 17.
Covid-19 deaths and infections declined across the Americas for an 8th consecutive week, the Pan American Health Organization (PAHO) said on Nov. 3, warning that a very high percentage of hospitalized cases now are unvaccinated people.
Covid-19 is slowly retreating across most of North, Central and South America, the Pan American Health Organization (PAHO) said on Oct. 27, reporting that last week the continent’s death and infection figures were the lowest in over a year.
According to a Wall Street Journal report, the preferred Covid-19 shot globally is the Pfizer-BioNTech vaccine.
While the United States, Canada and Mexico are reporting overall reductions in Covid-19 cases and deaths, new infections are increasing in the rest of the Americas, Pan American Health Organization (PAHO) Director Carissa Etienne said.
More than 1 million people have died from Covid-19 in North and South America, the Pan American Health Organization (PAHO) said.
A study showed the use of convalescent plasma provided no clinical benefit nor improved mortality in Covid-19 patients with pneumonia.
Using blood plasma from Covid-19 survivors to treat patients with severe pneumonia caused by the novel coronavirus showed little benefit, according to data released from a clinical trial in Argentina.